Skip to main content
Monday, November 16, 2026Nov 16

U.S. wants drug prices in TV ads: ‘Patients deserve to know’

In this July 10, 2018, file photo bottles of medicine ride on a belt at the Express Scripts mail-in pharmacy warehouse in Florence, N.J. On Monday, Oct. 15, the industry's largest trade group announced that dozens of drugmakers will start disclosing the prices for U.S. prescription drugs advertised on TV. The prices won't actually be shown in the TV commercials but the advertisement will include a website where the list price will be posted. (AP Photo/Julio Cortez, File)
In this July 10, 2018, file photo bottles of medicine ride on a belt at the Express Scripts mail-in pharmacy warehouse in Florence, N.J. On Monday, Oct. 15, the industry's largest trade group announced that dozens of drugmakers will start disclosing the prices for U.S. prescription drugs advertised on TV. The prices won't actually be shown in the TV commercials but the advertisement will include a website where the list price will be posted. (AP Photo/Julio Cortez, File)

TRENTON, N.J. (AP) – The federal government said Monday that it wants to force drugmakers to disclose prices for prescription medicines in their TV commercials.

The drug industry’s main trade group said drug companies are only willing to disclose the prices on their websites, not in commercials, and they’ll start doing that next spring.

Health and Human Services Secretary Alex Azar unveiled a proposal that would apply to all brand-name drugs covered by the Medicare and Medicaid programs, which is most medicines.

“Patients deserve to know what a given drug could cost when they’re being told about the benefits and risks it may have,” Azar said in prepared remarks. “They deserve to know if the drug company has pushed their prices to abusive levels. And they deserve to know this every time they see a drug advertised to them on TV.”

Most Americans don’t pay the full price for prescriptions – one reason drugmakers have opposed disclosing the list prices, arguing that would just confuse the public. But insurance plans base their copayments on the list price set by drugmakers. And patients with high-deductibles plans or no insurance sometimes pay full price.